Zetta Genomics is a Cambridge-based company established in 2018 that focuses on managing large-scale genomic data to advance precision medicine. The company operates a user-centric platform that facilitates connections between individuals and researchers, allowing users to opt in or out of studies related to various health conditions, including common disorders like eczema and diabetes, as well as rare diseases such as muscular dystrophy. By employing distributed database technology and robust security measures, Zetta Genomics ensures the privacy of genomic data while enabling scientists to access dynamic health and genetic datasets for personalized medicine research. The platform emphasizes transparency and control for users throughout the data-sharing process.
Z Factor Limited is a drug discovery company based in Cambridge, United Kingdom, established in 2014. The company focuses on identifying and developing therapeutic agents to address alpha-1-antitrypsin deficiency, a genetic disorder that leads to significant health complications. Z Factor's research aims to design novel therapeutic solutions that correct the misfolding of the Z variant of alpha-1-antitrypsin, addressing a critical medical need. Current treatment options are limited, primarily relying on lung or liver transplantation and augmentation therapy. Through its innovative approach, Z Factor seeks to create effective therapies that could improve the quality of life for those affected by this condition.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.